What Is Alanyl-Glutamine? Definition and What Research Reports

Definition

Alanyl-glutamine — written in the literature as L-alanyl-L-glutamine or abbreviated Ala-Gln — is a synthetic dipeptide in which L-alanine is joined to L-glutamine by a single peptide bond. It belongs to the class of nutrient or nutritional dipeptides rather than to the class of receptor-targeting signalling peptides, and its purpose in most research settings is straightforward: free glutamine is poorly soluble in water and degrades during heat sterilisation and storage, whereas the dipeptide form is far more soluble and stable, and is cleaved by peptidases to release the two constituent amino acids. That practical chemistry is why the term appears so often in parenteral nutrition formulations, in cell-culture media, and in animal-nutrition experiments where a stable glutamine source is required.

What Class of Molecule It Is, and Where It Comes From

Alanyl-glutamine is produced synthetically or enzymatically; it is not an endogenous hormone and has no known dedicated receptor. Structurally it is the simplest kind of peptide — two residues — which places it at the opposite end of the peptide spectrum from the larger, sequence-specific molecules (such as growth-hormone-releasing or incretin analogues) that dominate consumer peptide discussion. In biochemical terms it functions as a carrier or delivery form: the dipeptide is absorbed or taken up intact and then hydrolysed, so most of the literature treats it as a glutamine substitution strategy rather than as a distinct bioactive agent, although some papers explicitly frame it as a "dietary bioactive peptide" in its own right, as the 2021 mouse colitis paper did in its title (PMID 34046146).

How the term is used in peptide research

• As a glutamine source in media and formulations. Papers often compare Ala-Gln against free glutamine or against other glutamine dipeptides such as glycyl-glutamine.
• As a feed additive in animal science. Swine and poultry studies use it to examine growth, gut morphology and gene-expression endpoints.
• As a test compound in barrier and injury models. Intestinal epithelial cell lines, peritoneal-dialysis models, and rodent liver or colitis models appear repeatedly.

This page is for educational purposes only and is not medical advice; consult a licensed physician about any health question or before making decisions related to nutrition, supplementation, or medical treatment.

What the Published Literature Reports

Cell models of the intestinal epithelium

A 2017 in vitro study compared glutamine dipeptides as glutamine substitutes and reported that alanyl-glutamine, but not glycyl-glutamine, improved the proliferation of enterocytes in culture (PMID 28861626). In IPEC-J2 porcine intestinal epithelial cells, researchers examined the mycotoxin zearalenone and reported a protective effect of both glutamine and alanyl-glutamine against zearalenone-induced intestinal epithelial barrier dysfunction (PMID 33932823). A separate 2019 report using bovine jejunum epithelial cells found that alanyl-glutamine ameliorated lipopolysaccharide-induced inflammation and barrier function injury in that cell model (PMID 30773024).

Outside the gut, a 2020 study in Biomolecules reported that alanyl-glutamine restored tight junction organisation after disruption by a conventional peritoneal dialysis fluid (PMID 32823646). Taken together, these are mechanistic, cell-level observations about epithelial integrity — not clinical outcomes.

Animal feeding and growth studies

Livestock nutrition accounts for a large share of the published record. One 2019 study in weaned piglets reported that dietary alanyl-glutamine improved growth performance through maintenance of intestinal morphology and digestion–absorption function (PMID 30789107). An earlier piglet study examined intracellular signalling and reported that alanyl-glutamine supplementation regulated mTOR and ubiquitin–proteasome proteolysis signalling pathways (PMID 27155955). In poultry, a 2024 Poultry Science paper used transcriptomic analysis to describe ileal adaptations and growth responses in growing hens supplemented with the alanyl-glutamine dipeptide (PMID 39500264).

Rodent models of inflammation and tissue injury

In mice fed a methionine- and choline-deficient diet, the study reported that alanyl-glutamine protected against diet-induced steatohepatitis and fibrosis by modulating oxidative stress and inflammation (PMID 36145172). In a dextran sodium sulfate colitis model, researchers reported that the dietary peptide attenuated colitis while modulating gut microbiota composition (PMID 34046146). A 2018 rat experiment reported that oral administration of alanyl-glutamine and of glutamine improved random-pattern dorsal skin flap survival (PMID 30186572).

Study Snapshot

Adverse Events and Tolerability: What Studies Report

The verified papers summarised here were designed around efficacy and mechanism endpoints — proliferation, barrier and tight-junction markers, growth performance, transcriptomic and signalling readouts, histology — rather than around systematic safety surveillance in humans. None of the cell studies, such as the enterocyte proliferation comparison (PMID 28861626) or the tight-junction work in a peritoneal dialysis fluid model (PMID 32823646), can speak to human tolerability, and the animal feeding studies in piglets and hens reported production and tissue endpoints rather than a human adverse-event profile (PMID 39500264). Readers looking for safety information should treat this body of work as silent on the question rather than reassuring about it.

Limitations of the Current Evidence Base

• Species and system. The findings above come from cultured cells, rodents, piglets and hens. Results in those systems do not automatically transfer to people.
• Comparator design. Several studies compared alanyl-glutamine against free glutamine or another dipeptide, so a reported difference may reflect solubility and stability as much as any distinct property of the molecule (PMID 28861626).
• Model-specific stressors. Effects were reported against specific insults — lipopolysaccharide, zearalenone, dextran sodium sulfate, a methionine- and choline-deficient diet — and each of those is an artificial challenge rather than a naturally occurring human condition (PMID 34046146).
• Heterogeneous endpoints. Growth performance in livestock, transcriptomic signatures, flap survival and histological fibrosis scores are not interchangeable outcomes and cannot be pooled into a single claim.

Related Terms

• Glutamine — the free amino acid that alanyl-glutamine delivers after hydrolysis.
• Glycyl-glutamine — an alternative glutamine dipeptide used as a comparator in the 2017 enterocyte study (PMID 28861626).
• Dipeptide — any peptide of two amino acid residues.
• Intestinal barrier / tight junctions — the epithelial structures measured in several of the cell studies above (PMID 30773024).

References

• Alanyl-glutamine but not glycyl-glutamine improved the proliferation of enterocytes as glutamine substitution in vitro (Amino Acids, 2017)
• Alanyl-glutamine supplementation regulates mTOR and ubiquitin proteasome proteolysis signaling pathways in piglets (Nutrition, 2016)
• Transcriptomic analysis of ileal adaptations and growth responses in growing hens supplemented with alanyl-glutamine dipeptide (Poultry Science, 2024)
• Protective effect of glutamine and alanyl-glutamine against zearalenone-induced intestinal epithelial barrier dysfunction in IPEC-J2 cells (Research in Veterinary Science, 2021)
• Alanyl-Glutamine Protects Mice against Methionine- and Choline-Deficient-Diet-Induced Steatohepatitis and Fibrosis by Modulating Oxidative Stress and Inflammation (Nutrients, 2022)
• Alanyl-glutamine ameliorates lipopolysaccharide-induced inflammation and barrier function injury in bovine jejunum epithelial cells (Biochemistry and Cell Biology, 2019)
• Dietary Bioactive Peptide Alanyl-Glutamine Attenuates Dextran Sodium Sulfate-Induced Colitis by Modulating Gut Microbiota (Oxidative Medicine and Cellular Longevity, 2021)
• Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid (Biomolecules, 2020)
• Oral administration of alanyl-glutamine and glutamine improve random pattern dorsal skin flap survival in rats (Iranian Journal of Basic Medical Sciences, 2018)
• Dietary alanyl-glutamine improves growth performance of weaned piglets through maintaining intestinal morphology and digestion-absorption function (Animal, 2019)